Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576498 · ClinicalTrials.gov registry record · NA
Novel Imaging Techniques in Barrett's Esophagus
A NA study, sponsored by Midwest Biomedical Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT00576498 is a NA study that has completed, run by Midwest Biomedical Research Foundation. The registered enrollment target is 130 participants.
The verdict
NCT00576498, a NA study, has completed, sponsored by Midwest Biomedical Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
Primary Aim: In patients with endoscopically suspected BE, compared to standard endoscopy, novel techniques (NBI and AFI) with target biopsies will * Detect more patients with intestinal metaplasia * Detect more areas of high grade dysplasia * Require fewer biopsies and a shorter time for procedure completion Secondary Aim: * Compare the yield of high-grade dysplasia(HGD)using NBI/AFI versus standard endoscopy with biopsy. * Compare the number of biopsies and procedure times for NBI/AFI versus standard endoscopy with biopsy. * Compare the inter-observer variability in classifying different mucosal and vascular patterns observed by NBI/AFI using kappa statistics.
Interventions
- OTHER NBI-AFI imaging
- OTHER Standard Endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2005-10 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576498
The ClinicalTrials.gov registry entry for NCT00576498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Biomedical Research Foundation, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NBI-AFI imaging is the first listed.
NCT00576498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576498 about?
NCT00576498 is a clinical study titled "Novel Imaging Techniques in Barrett's Esophagus". Primary Aim: In patients with endoscopically suspected BE, compared to standard endoscopy, novel techniques (NBI and AFI) with target biopsies will * Detect more patients with intestinal metaplasia * Detect more areas of high grade dysplasia * Require fewer biopsies and a shorter time for procedure...
What is the current status of trial NCT00576498?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2005-10. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00576498?
The interventions under investigation include: NBI-AFI imaging (OTHER), Standard Endoscopy (OTHER).
Who is sponsoring clinical trial NCT00576498?
This trial is sponsored by Midwest Biomedical Research Foundation, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.